All Stories

  1. Eating Disorders and Parkinson’s Disease - 1: Comorbidities, Neurobiology and Family History

    Article • January 2026, openRxiv

    Professor Irene Litvan

  2. Eating Disorders and Parkinson’s Disease - 2: Population Burden, Genetic Epidemiology and Shared Genomics

    Article • January 2026, openRxiv

    Professor Irene Litvan

  3. CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies

    Article • Neurology, December 2025, Wolters Kluwer Health

    Professor Irene Litvan

  4. Characteristics and mechanisms of cognitive impairment in Parkinson disease

    Article • Nature Reviews Neurology, December 2025, Springer Science + Business Media

    Professor Irene Litvan

  5. An Alternative Approach to the Finger‐Tapping Test in Parkinsonian Patients: Finger to Crease Instead of Finger to Tip

    Article • Movement Disorders Clinical Practice, November 2025, Wiley

    Professor Irene Litvan

  6. Acute Pharmacodynamic Effects of Oral Levodopa on Blood Pressure in Parkinson's Disease

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, October 2025, Wiley

    Professor Irene Litvan

  7. Progressive Supranuclear Palsy—A Global Review

    Article • Movement Disorders Clinical Practice, September 2025, Wiley

    Professor Irene Litvan, Dr Prashanth L Kukkle

  8. Early Subtypes and Progressions of Progressive Supranuclear Palsy: A Data-Driven Brain Bank Study

    Article • July 2025, Cold Spring Harbor Laboratory Press

    Professor Irene Litvan

  9. Differential memory enrichment of cytotoxic CD4 T cells in Parkinson’s disease patients reactive to α-synuclein

    Article • April 2025, Cold Spring Harbor Laboratory Press

    Professor Irene Litvan

  10. T cell responses towards PINK1 and α-synuclein are elevated in prodromal Parkinson’s disease

    Article • April 2025, Cold Spring Harbor Laboratory Press

    Professor Irene Litvan

  11. Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies

    Article • Neurology, August 2024, Wolters Kluwer Health

    Professor Irene Litvan

  12. Why Crafting a Compelling Abstract Is Important to Summarize Research Findings

    Article • Movement Disorders Clinical Practice, June 2024, Wiley

    Professor Irene Litvan

  13. Biosensor Strip for Rapid On‐site Assessment of Levodopa Pharmacokinetics along with Motor Performance in Parkinson's Disease

    Article • Angewandte Chemie, May 2024, Wiley

    Professor Irene Litvan

  14. Biosensor Strip for Rapid On‐site Assessment of Levodopa Pharmacokinetics along with Motor Performance in Parkinson's Disease

    Article • Angewandte Chemie, May 2024, Wiley

    Professor Irene Litvan

  15. PINK1 is a target of T cell responses in Parkinson’s disease

    Article • February 2024, Cold Spring Harbor Laboratory Press

    Professor Irene Litvan

  16. Nicked tRNAs are stable reservoirs of tRNA halves in cells and biofluids

    Article • Proceedings of the National Academy of Sciences, January 2023, Proceedings of the National Academy of Sciences

    Juan Tosar, Professor Irene Litvan

  17. CBD diagnostic criteria: exclusions as important as inclusions

    Article • Journal of Neurology Neurosurgery & Psychiatry, November 2022, BMJ

    Professor Irene Litvan

  18. Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies

    Article • Journal of Neuropathology & Experimental Neurology, October 2022, Oxford University Press (OUP)

    Professor Irene Litvan

  19. Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

    Article • Nature Medicine, October 2022, Springer Science + Business Media

    Professor Irene Litvan

  20. Nicked tRNAs are stable reservoirs of tRNA halves in cells and biofluids

    Article • September 2022, Cold Spring Harbor Laboratory Press

    Professor Irene Litvan

  21. Sex Differences for Clinical Correlates of Alzheimer's Pathology in People with Lewy Body Pathology

    Article • Movement Disorders, May 2022, Wiley

    Ece Bayram, Professor Irene Litvan

  22. A Modified Progressive Supranuclear Palsy Rating Scale for Virtual Assessments

    Article • Movement Disorders, April 2022, Wiley

    Professor Irene Litvan

  23. Physician‐Assisted Dying: Access and Utilization in Patients with Movement Disorders

    Article • Movement Disorders, February 2022, Wiley

    Ece Bayram, Professor Irene Litvan

  24. Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

    Article • Nature Medicine, August 2021, Springer Science + Business Media

    Professor Irene Litvan

  25. The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism

    Article • npj Parkinson s Disease, March 2021, Springer Science + Business Media

    Professor Irene Litvan

  26. Orthostatic hypotension preceding dementia with Lewy bodies by over 15 years: a clinicopathologic case report

    Article • Clinical Autonomic Research, September 2020, Springer Science + Business Media

    Professor Irene Litvan

  27. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?

    Article • Parkinsonism & Related Disorders, December 2019, Elsevier

    Professor Irene Litvan

  28. Hypertension and progressive supranuclear palsy

    Article • Parkinsonism & Related Disorders, August 2019, Elsevier

    Professor Irene Litvan

  29. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability

    Article • Parkinsonism & Related Disorders, July 2019, Elsevier

    Professor Irene Litvan

  30. End of life planning in parkinsonian diseases

    Article • Parkinsonism & Related Disorders, May 2019, Elsevier

    Professor Irene Litvan

  31. The virtual reality of Parkinson's disease freezing of gait: A systematic review

    Article • Parkinsonism & Related Disorders, April 2019, Elsevier

    Ece Bayram, Professor Irene Litvan

  32. Progress in the treatment of Parkinson-Plus syndromes

    Article • Parkinsonism & Related Disorders, February 2019, Elsevier

    Professor Irene Litvan

  33. Fall Prediction and Prevention Systems: Recent Trends, Challenges, and Future Research Directions

    Article • Sensors, November 2017, MDPI AG

    Professor Irene Litvan

  34. Therapeutic options for Progressive Supranuclear Palsy including investigational drugs

    Article • Expert Opinion on Orphan Drugs, June 2017, Taylor & Francis

    Professor Irene Litvan

  35. The Role of Stress as a Risk Factor for Progressive Supranuclear Palsy

    Article • Journal of Parkinson’s Disease, May 2017, IOS Press

    Professor Irene Litvan

  36. Which ante mortem clinical features predict progressive supranuclear palsy pathology?

    Article • Movement Disorders, May 2017, Wiley

    Dr Maria Stamelou, Professor Irene Litvan

  37. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

    Article • Movement Disorders, May 2017, Wiley

    Dr Maria Stamelou, Professor Irene Litvan

  38. Psychometric Properties and Characteristics of the North-East Visual Hallucinations Interview in Parkinson's Disease

    Article • Movement Disorders Clinical Practice, March 2017, Wiley

    Professor Irene Litvan

  39. Neuropsychiatric Predictors of Cognitive Decline in Parkinson Disease: A Longitudinal Study

    Article • American Journal of Geriatric Psychiatry, March 2017, Elsevier

    Professor Irene Litvan

  40. Understanding falls in progressive supranuclear palsy

    Article • Parkinsonism & Related Disorders, February 2017, Elsevier

    Professor Irene Litvan

  41. Progression of brain atrophy in PSP and CBS over 6 months and 1 year

    Article • Neurology, October 2016, Wolters Kluwer Health

    Professor Irene Litvan

  42. Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale

    Article • Movement Disorders, October 2016, Wiley

    Professor Irene Litvan

  43. Abolishing the 1-year rule: How much evidence will be enough?

    Article • Movement Disorders, September 2016, Wiley

    Professor Irene Litvan

  44. Environmental Exposures and Parkinson’s Disease

    Article • International Journal of Environmental Research and Public Health, September 2016, MDPI AG

    Professor Irene Litvan

  45. Cognitive functioning in individuals with Parkinson’s disease and traumatic brain injury: A longitudinal study

    Article • Parkinsonism & Related Disorders, September 2016, Elsevier

    Professor Irene Litvan

  46. Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy

    Article • Parkinsonism & Related Disorders, July 2016, Elsevier

    Professor Irene Litvan

  47. Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials

    Article • Parkinsonism & Related Disorders, July 2016, Elsevier

    Professor Irene Litvan

  48. Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study

    Article • PLOS One, June 2016, PLOS

    Professor Irene Litvan

  49. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease

    Article • Parkinsonism & Related Disorders, June 2016, Elsevier

    Professor Irene Litvan

  50. α-synuclein genetic variability: A biomarker for dementia in Parkinson disease

    Article • Annals of Neurology, May 2016, Wiley

    Professor Irene Litvan

  51. The new definition and diagnostic criteria of Parkinson's disease

    Article • The Lancet Neurology, May 2016, Elsevier

    Professor Irene Litvan

  52. Technology in Parkinson's disease: Challenges and opportunities

    Article • Movement Disorders, April 2016, Wiley

    Professor Irene Litvan

  53. Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

    Article • Movement Disorders, March 2016, Wiley

    Dr Maria Stamelou, Professor Irene Litvan

  54. Relationship between uric acid levels and progressive supranuclear palsy

    Article • Movement Disorders, February 2016, Wiley

    Professor Irene Litvan

  55. Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study

    Article • Movement Disorders, February 2016, Wiley

    Professor Irene Litvan

  56. Neuropsychiatric symptoms and their impact on quality of life in multiple system atrophy

    Article • Cogent Psychology, January 2016, Taylor & Francis

    Professor Irene Litvan

  57. Progressive supranuclear palsy: progression and survival

    Article • Journal of Neurology, December 2015, Springer Science + Business Media

    Professor Irene Litvan

  58. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy

    Article • Acta Neuropathologica, December 2015, Springer Science + Business Media

    Dr William Stewart, Professor Irene Litvan

  59. Structural MRI Correlates of Episodic Memory Processes in Parkinson’s Disease Without Mild Cognitive Impairment

    Article • Journal of Parkinson’s Disease, November 2015, IOS Press

    Professor Irene Litvan

  60. Swallowing disturbances in the corticobasal syndrome

    Article • Parkinsonism & Related Disorders, November 2015, Elsevier

    Professor Irene Litvan

  61. Clinimetric Analysis of the Motor Section of the Progressive Supranuclear Palsy Rating Scale: Reliability and Factor Analysis

    Article • Movement Disorders Clinical Practice, October 2015, Wiley

    Professor Irene Litvan

  62. Head injury exposure in PSP: a case-control study

    Article • Journal of the Neurological Sciences, October 2015, Elsevier

    Professor Irene Litvan

  63. MDS clinical diagnostic criteria for Parkinson's disease

    Article • Movement Disorders, October 2015, Wiley

    Professor Irene Litvan

  64. MDS research criteria for prodromal Parkinson's disease

    Article • Movement Disorders, October 2015, Wiley

    Professor Irene Litvan

  65. The RAB39B p.G192R mutation causes X-linked dominant Parkinson’s disease

    Article • Molecular Neurodegeneration, September 2015, Springer Science + Business Media

    Professor Irene Litvan

  66. Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers)

    Article • Quality of Life Research, August 2015, Springer Science + Business Media

    Professor Irene Litvan

  67. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

    Article • Nature Communications, June 2015, Springer Science + Business Media

    Professor Irene Litvan

  68. Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report

    Article • Movement Disorders Clinical Practice, May 2015, Wiley

    Professor Irene Litvan

  69. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

    Article • Movement Disorders, March 2015, Wiley

    Professor Irene Litvan

  70. NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases

    Article • Neurobiology of Aging, March 2015, Elsevier

    Professor Irene Litvan, Dr. Rita Guerreiro

  71. Pathophysiology, genetics, clinical features, diagnosis and therapeutic trials in progressive supranuclear palsy

    Article • Expert Opinion on Orphan Drugs, February 2015, Informa Healthcare

    Professor Irene Litvan

  72. The Wearable Multimodal Monitoring System: A Platform to Study Falls and Near-Falls in the Real-World

    Article • January 2015, Springer Science + Business Media

    Professor Irene Litvan

  73. Correcting for Demographic Variables on the Modified Telephone Interview for Cognitive Status

    Article • American Journal of Geriatric Psychiatry, December 2014, Elsevier

    Professor Irene Litvan

  74. A disposable electrochemical biosensor for l-DOPA determination in undiluted human serum

    Article • Electrochemistry Communications, November 2014, Elsevier

    Professor Irene Litvan

  75. Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, October 2014, Wiley

    Professor Irene Litvan

  76. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

    Article • Nature Genetics, July 2014, Springer Science + Business Media

    Professor Irene Litvan, Dr. Rita Guerreiro

  77. Faculty Opinions recommendation of Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study.

    Article • July 2014, F1000Research

    Professor Irene Litvan

  78. P3‐165: MILD COGNITIVE IMPAIRMENT AMONG PARKINSON'S DISEASE SUBJECTS IN THE UNIFORM DATA SET

    Article • Alzheimer s & Dementia, July 2014, Wiley

    Professor Irene Litvan

  79. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

    Article • The Lancet Neurology, July 2014, Elsevier

    Professor Irene Litvan

  80. Corticobasal Degeneration

    Article • Seminars in Neurology, June 2014, Thieme Publishing Group

    Professor Irene Litvan

  81. The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment

    Article • Parkinsonism & Related Disorders, June 2014, Elsevier

    Professor Irene Litvan

  82. Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status

    Article • Parkinsonism & Related Disorders, May 2014, Elsevier

    Professor Irene Litvan

  83. A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease

    Article • JAMA Neurology, May 2014, American Medical Association (AMA)

    Professor Irene Litvan, MD Michael S Okun

  84. Cognition in movement disorders: Where can we hope to be in ten years?

    Article • Movement Disorders, April 2014, Wiley

    Professor Irene Litvan

  85. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease

    Article • Movement Disorders, March 2014, Wiley

    Professor Irene Litvan

  86. Instrumental activities of daily living are impaired in Parkinson’s disease patients with mild cognitive impairment.

    Article • Neuropsychology, March 2014, American Psychological Association (APA)

    Professor Irene Litvan

  87. Rate of decline in progressive supranuclear palsy

    Article • Movement Disorders, February 2014, Wiley

    Professor Irene Litvan

  88. A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy

    Article • Movement Disorders, February 2014, Wiley

    Professor Irene Litvan

  89. Dissociation of Neural Mechanisms for Intersensory Timing Deficits in Parkinson’s Disease

    Article • Timing & Time Perception, January 2014, De Gruyter

    Professor Irene Litvan

  90. Pan-American Consortium of Multiple System Atrophy (PANMSA). A Pan-American multicentre cohort study of Multiple System Atrophy

    Article • Journal of Parkinson’s Disease, January 2014, IOS Press

    Professor Irene Litvan, Dr Mayela Rodríguez-Violante

  91. Parkinson's Disease Mild Cognitive Impairment: Application and Validation of the Criteria

    Article • Journal of Parkinson’s Disease, January 2014, IOS Press

    Professor Irene Litvan

  92. Behavioral abnormalities in progressive supranuclear palsy

    Article • Psychiatry Research, December 2013, Elsevier

    Professor Irene Litvan

  93. Faculty Opinions recommendation of Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.

    Article • November 2013, F1000Research

    Professor Irene Litvan

  94. Primary Health Care Providers' Knowledge Gaps on Parkinson's Disease

    Article • Educational Gerontology, November 2013, Taylor & Francis

    Professor Irene Litvan

  95. Predictors of performance-based measures of instrumental activities of daily living in nondemented patients with Parkinson’s disease

    Article • Journal of Clinical and Experimental Neuropsychology, November 2013, Taylor & Francis

    Professor Irene Litvan

  96. Parkinsonian Syndromes

    Article • Continuum, October 2013, Wolters Kluwer Health

    Professor Irene Litvan

  97. Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease

    Article • Movement Disorders, September 2013, Wiley

    Professor Irene Litvan

  98. Neuropsychiatric and cognitive disorders in other parkinsonian disorders

    Article • August 2013, Cambridge University Press

    Professor Irene Litvan

  99. Faculty Opinions recommendation of The natural history of multiple system atrophy: a prospective European cohort study.

    Article • July 2013, F1000Research

    Professor Irene Litvan

  100. P4–096: APOE‐ɛ4 and clinical progression in Parkinson's disease

    Article • Alzheimer s & Dementia, July 2013, Wiley

    Professor Irene Litvan

  101. The meaning of a “hippo” response on the Montreal Cognitive Assessment in Parkinson's disease

    Article • Parkinsonism & Related Disorders, April 2013, Elsevier

    Professor Irene Litvan

  102. Measuring mild cognitive impairment in patients with Parkinson's disease

    Article • Movement Disorders, March 2013, Wiley

    Professor Irene Litvan

  103. Criteria for the diagnosis of corticobasal degeneration

    Article • Neurology, January 2013, Wolters Kluwer Health

    Professor Irene Litvan

  104. Functional impairment in progressive supranuclear palsy

    Article • Neurology, January 2013, Wolters Kluwer Health

    Professor Irene Litvan

  105. White-Matter Changes Correlate with Cognitive Functioning in Parkinson’s Disease

    Article • Frontiers in Neurology, January 2013, Frontiers

    Professor Irene Litvan

  106. Long-duration Parkinson's disease: Role of lateralization of motor features

    Article • Parkinsonism & Related Disorders, January 2013, Elsevier

    Professor Irene Litvan, Professor Helio A. G. Teive

  107. Impact of Mild Cognitive Impairment on Health-Related Quality of Life in Parkinson's Disease

    Article • Dementia and Geriatric Cognitive Disorders, January 2013, Karger Publishers

    Professor Irene Litvan

  108. The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer’s disease

    Article • Acta Neuropathologica Communications, January 2013, Springer Science + Business Media

    Professor Irene Litvan

  109. Toward magnetic resonance imaging biomarkers for progressive supranuclear palsy and multisystem atrophy

    Article • Movement Disorders, December 2012, Wiley

    Professor Irene Litvan

  110. Faculty Opinions recommendation of Pareidolias: complex visual illusions in dementia with Lewy bodies.

    Article • November 2012, F1000Research

    Professor Irene Litvan

  111. Faculty Opinions recommendation of Parkinson subtypes progress differently in clinical course and imaging pattern.

    Article • November 2012, F1000Research

    Professor Irene Litvan

  112. Executive Dysfunction Is the Primary Cognitive Impairment in Progressive Supranuclear Palsy

    Article • Archives of Clinical Neuropsychology, November 2012, Oxford University Press (OUP)

    Professor Irene Litvan

  113. Reply: Mild cognitive impairment in de novo Parkinson's disease according to Movement Disorder guidelines

    Article • Movement Disorders, November 2012, Wiley

    Professor Irene Litvan

  114. The pill questionnaire in a nondemented Parkinson's disease population

    Article • Movement Disorders, August 2012, Wiley

    Professor Irene Litvan

  115. Faculty Opinions recommendation of Clinical features of Parkinson disease when onset of diabetes came first: A case-control study.

    Article • May 2012, F1000Research

    Professor Irene Litvan

  116. Pan-American Consortium of Multiple System Atrophy. Preliminary Report (P06.079)

    Article • Neurology, April 2012, Wolters Kluwer Health

    Professor Irene Litvan, Dr Mayela Rodríguez-Violante

  117. Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study

    Article • BMC Medical Genetics, March 2012, Springer Science + Business Media

    Professor Irene Litvan

  118. Meta-analysis of Parkinson's Disease: Identification of a novel locus, RIT2

    Article • Annals of Neurology, March 2012, Wiley

    Professor Irene Litvan

  119. Phosphorylated  -Synuclein in Parkinson's Disease

    Article • Science Translational Medicine, February 2012, American Association for the Advancement of Science

    Professor Irene Litvan

  120. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

    Article • Movement Disorders, January 2012, Wiley

    Professor Irene Litvan

  121. Annonacin in Asimina triloba fruit: Implication for neurotoxicity

    Article • NeuroToxicology, January 2012, Elsevier

    Professor Irene Litvan

  122. Roles of Education and IQ in Cognitive Reserve in Parkinson’s Disease-Mild Cognitive Impairment

    Article • Dementia and Geriatric Cognitive Disorders Extra, January 2012, Karger Publishers

    Professor Irene Litvan

  123. Faculty Opinions recommendation of Quantitative EEG as a predictive biomarker for Parkinson disease dementia.

    Article • November 2011, F1000Research

    Professor Irene Litvan

  124. Cytokine expression and microglial activation in progressive supranuclear palsy

    Article • Parkinsonism & Related Disorders, November 2011, Elsevier

    Professor Irene Litvan

  125. Faculty Opinions recommendation of α-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies.

    Article • October 2011, F1000Research

    Professor Irene Litvan

  126. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome

    Article • Brain, September 2011, Oxford University Press (OUP)

    Professor Irene Litvan

  127. Parkinsonism and Frontotemporal Dementia: The Clinical Overlap

    Article • Journal of Molecular Neuroscience, September 2011, Springer Science + Business Media

    Professor Irene Litvan

  128. Progressive Supranuclear Palsy and Corticobasal Degeneration

    Article • September 2011, Wiley

    Professor Irene Litvan

  129. Brain-Lung-Thyroid Disease

    Article • Journal of Child Neurology, August 2011, SAGE Publications

    Professor Irene Litvan

  130. Copy Number Variation in Familial Parkinson Disease

    Article • PLOS One, August 2011, PLOS

    Professor Irene Litvan

  131. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

    Article • Nature Genetics, June 2011, Springer Science + Business Media

    Prof. Herbert Budka, Dr Christopher M Morris, Professor Irene Litvan

  132. MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI

    Article • Movement Disorders, June 2011, Wiley

    Professor Irene Litvan

  133. Faculty Opinions recommendation of Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.

    Article • May 2011, F1000Research

    Professor Irene Litvan

  134. Milestones in atypical and secondary Parkinsonisms

    Article • Movement Disorders, May 2011, Wiley

    Professor Irene Litvan

  135. Assessment of cognition in early dementia

    Article • Alzheimer s & Dementia, May 2011, Wiley

    Professor Irene Litvan

  136. Woman with gait impairment and difficulty reading

    Article • April 2011, Cambridge University Press

    Professor Irene Litvan

  137. Faculty Opinions recommendation of Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

    Article • February 2011, F1000Research

    Professor Irene Litvan

  138. A recommended scale for cognitive screening in clinical trials of Parkinson's disease

    Article • Movement Disorders, September 2010, Wiley

    Professor Irene Litvan, Jason Brandt

  139. Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson’s disease

    Article • Parkinsonism & Related Disorders, September 2010, Elsevier

    Professor Irene Litvan

  140. Faculty Opinions recommendation of Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease.

    Article • July 2010, F1000Research

    Professor Irene Litvan

  141. A long-term study of istradefylline in subjects with fluctuating Parkinson's disease

    Article • Parkinsonism & Related Disorders, July 2010, Elsevier

    Professor Irene Litvan

  142. Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease

    Article • Journal of Neurology Neurosurgery & Psychiatry, June 2010, BMJ

    Professor Irene Litvan

  143. A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy

    Article • Movement Disorders, June 2010, Wiley

    Professor Irene Litvan

  144. Faculty Opinions recommendation of Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease.

    Article • May 2010, F1000Research

    Professor Irene Litvan

  145. H1/H1 genotype influences symptom severity in corticobasal syndrome

    Article • Movement Disorders, April 2010, Wiley

    Professor Irene Litvan

  146. Faculty Opinions recommendation of Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.

    Article • March 2010, F1000Research

    Professor Irene Litvan

  147. Bradykinesia

    Article • January 2010, Elsevier

    Professor Irene Litvan

  148. Tauopathies

    Article • January 2010, Elsevier

    Professor Irene Litvan

  149. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

    Article • The Lancet Neurology, December 2009, Elsevier

    Professor Irene Litvan

  150. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

    Article • The Lancet Neurology, December 2009, Elsevier

    Professor Irene Litvan

  151. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort

    Article • Neurology, November 2009, Wolters Kluwer Health

    Professor Irene Litvan

  152. Genomewide association study for onset age in Parkinson disease

    Article • BMC Medical Genetics, September 2009, Springer Science + Business Media

    Professor Irene Litvan

  153. Faculty Opinions recommendation of Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration.

    Article • August 2009, F1000Research

    Professor Irene Litvan

  154. Faculty Opinions recommendation of Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study.

    Article • May 2009, F1000Research

    Professor Irene Litvan

  155. Faculty Opinions recommendation of A controlled trial of antidepressants in patients with Parkinson disease and depression.

    Article • March 2009, F1000Research

    Professor Irene Litvan

  156. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options

    Article • European Journal of Neurology, March 2009, Wiley

    Professor Irene Litvan

  157. Review article Progressive supranuclear palsy revisited

    Article • Acta Neurologica Scandinavica, January 2009, Hindawi Publishing Corporation

    Professor Irene Litvan

  158. Reply: Corticobasal syndrome with Alzheimer's disease pathology

    Article • Movement Disorders, January 2009, Wiley

    Professor Irene Litvan

  159. Parkinson’s Disease: An Overview of Pathogenesis

    Article • January 2009, Springer Science + Business Media

    Professor Irene Litvan

  160. Is it PD, PSP, CBD, DLB, or MSA?

    Article • November 2008, Taylor & Francis

    Professor Irene Litvan

  161. Faculty Opinions recommendation of Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.

    Article • November 2008, F1000Research

    Professor Irene Litvan

  162. Genomewide association study for susceptibility genes contributing to familial Parkinson disease

    Article • Human Genetics, November 2008, Springer Science + Business Media

    Professor Irene Litvan

  163. The Gly2019Ser mutation in LRRK2is not fully penetrant in familial Parkinson's disease: the GenePD study

    Article • BMC Medicine, November 2008, Springer Science + Business Media

    Professor Irene Litvan

  164. Faculty Opinions recommendation of Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

    Article • September 2008, F1000Research

    Professor Irene Litvan

  165. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study

    Article • Movement Disorders, July 2008, Wiley

    Professor Irene Litvan

  166. Replication of association between ELAVL4 and Parkinson disease: the GenePD study

    Article • Human Genetics, June 2008, Springer Science + Business Media

    Professor Irene Litvan

  167. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The GenePD Study

    Article • Neurology, May 2008, Wolters Kluwer Health

    Professor Irene Litvan

  168. Faculty Opinions recommendation of Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia.

    Article • May 2008, F1000Research

    Professor Irene Litvan

  169. Progressive supranuclear palsy and corticobasal degeneration: similarities and differences

    Article • Future Neurology, May 2008, Future Medicine

    Professor Irene Litvan

  170. Adenosine A2Areceptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)

    Article • Annals of Neurology, March 2008, Wiley

    Professor Irene Litvan

  171. Preface

    Article • January 2008, Elsevier

    Professor Irene Litvan

  172. Current and future therapeutic approaches in progressive supranuclear palsy

    Article • January 2008, Elsevier

    Professor Irene Litvan

  173. Biology and Neuropathology of Dementia in Syphilis and Lyme Disease

    Article • January 2008, Elsevier

    Professor Irene Litvan

  174. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

    Article • January 2008, Elsevier

    Professor Irene Litvan

  175. Clinical and Therapeutic Aspects of Dementia in Syphilis and Lyme Disease

    Article • January 2008, Elsevier

    Professor Irene Litvan

  176. Clinical aspects and biology of normal pressure hydrocephalus

    Article • January 2008, Elsevier

    Professor Irene Litvan

  177. Clinical aspects of Parkinson dementia

    Article • January 2008, Elsevier

    Professor Irene Litvan

  178. Clinical symptoms in Alzheimer's disease

    Article • January 2008, Elsevier

    Professor Irene Litvan

  179. History of Dementia

    Article • January 2008, Elsevier

    Professor Irene Litvan

  180. Mild cognitive impairment

    Article • January 2008, Elsevier

    Professor Irene Litvan

  181. Neuropathology and genetics of corticobasal degeneration

    Article • January 2008, Elsevier

    Professor Irene Litvan

  182. Neuropathology of Pick body disease

    Article • January 2008, Elsevier

    Professor Irene Litvan

  183. Neuropathology of Hereditary Forms of Frontotemporal Dementia and Parkinsonism

    Article • January 2008, Elsevier

    Professor Irene Litvan

  184. Perspectives of Alzheimer's disease treatments

    Article • January 2008, Elsevier

    Professor Irene Litvan

  185. Quality of Life in Dementias

    Article • January 2008, Elsevier

    Professor Irene Litvan

  186. The Epidemiology of vascular dementia

    Article • January 2008, Elsevier

    Professor Irene Litvan

  187. The Neuropathology of Vascular and Mixed Dementia and Vascular Cognitive Impairment

    Article • January 2008, Elsevier

    Professor Irene Litvan

  188. Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

    Article • Movement Disorders, December 2007, Wiley

    Professor Irene Litvan

  189. Update of atypical parkinsonian disorders

    Article • Current Opinion in Neurology, August 2007, Wolters Kluwer Health

    Professor Irene Litvan

  190. Clinical diagnostic criteria for dementia associated with Parkinson's disease

    Article • Movement Disorders, May 2007, Wiley

    Professor Irene Litvan

  191. The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part II

    Article • Journal of Neuropathology & Experimental Neurology, May 2007, Oxford University Press (OUP)

    Professor Irene Litvan

  192. The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I

    Article • Journal of Neuropathology & Experimental Neurology, April 2007, Oxford University Press (OUP)

    Professor Irene Litvan

  193. Identification of a Novel Risk Locus for Progressive Supranuclear Palsy by a Pooled Genomewide Scan of 500,288 Single-Nucleotide Polymorphisms

    Article • The American Journal of Human Genetics, April 2007, Elsevier

    Professor Irene Litvan

  194. Faculty Opinions recommendation of Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial.

    Article • March 2007, F1000Research

    Professor Irene Litvan

  195. Faculty Opinions recommendation of Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease.

    Article • January 2007, F1000Research

    Professor Irene Litvan

  196. Neurobiology of Progressive Supranuclear Palsy

    Article • January 2007, Elsevier

    Professor Irene Litvan

  197. Unraveling progressive supranuclear palsy: from the bedsideback to the bench

    Article • Parkinsonism & Related Disorders, January 2007, Elsevier

    Professor Irene Litvan

  198. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: The GenePD Study

    Article • Neurology, December 2006, Wolters Kluwer Health

    Professor Irene Litvan

  199. Alzheimer's disease presenting as corticobasal syndrome

    Article • Movement Disorders, September 2006, Wiley

    Professor Irene Litvan

  200. Measuring quality of life in PSP

    Article • Neurology, July 2006, Wolters Kluwer Health

    Professor Irene Litvan

  201. Faculty Opinions recommendation of Compulsive drug use linked to sensitized ventral striatal dopamine transmission.

    Article • June 2006, F1000Research

    Professor Irene Litvan

  202. Atypical Parkinsonian Disorders--Clinical and Research Aspects * Edited by Irene Litvan * Human Press, 2005. ISBN 1-588-29-331-9. $175.00

    Article • Age and Ageing, June 2006, Oxford University Press (OUP)

    Professor Irene Litvan

  203. Influence of Heterozygosity for Parkin Mutation on Onset Age in Familial Parkinson Disease

    Article • Archives of Neurology, June 2006, American Medical Association (AMA)

    Professor Irene Litvan

  204. Current and future treatments in progressive supranuclear palsy

    Article • Current Treatment Options in Neurology, May 2006, Springer Science + Business Media

    Professor Irene Litvan

  205. Penguins and hummingbirds: Midbrain atrophy in progressive supranuclear palsy

    Article • Neurology, March 2006, Wolters Kluwer Health

    Professor Irene Litvan

  206. Faculty Opinions recommendation of Substantia nigra tangles are related to gait impairment in older persons.

    Article • March 2006, F1000Research

    Professor Irene Litvan

  207. Faculty Opinions recommendation of A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.

    Article • March 2006, F1000Research

    Professor Irene Litvan

  208. Book Review Drug Induced Movement Disorders Second edition. Edited by Stewart A. Factor, Anthony E. Lang, and William J. Weiner. 466 pp. Malden, Mass., Blackwell Futura, 2005. $120. 1-4051-2619-1

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2006, New England Journal of Medicine (NEJM/MMS)

    Professor Irene Litvan

  209. Lrrk2 and Lewy body disease

    Article • Annals of Neurology, January 2006, Wiley

    Professor Irene Litvan

  210. Midbrain atrophy in progressive supranuclear palsy: comparison of two dimensional planimetric- with three dimensional volumetric measurements

    Article • Aktuelle Neurologie, January 2006, Thieme Publishing Group

    Professor Irene Litvan

  211. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study

    Article • Neurology, December 2005, Wolters Kluwer Health

    Professor Irene Litvan

  212. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

    Article • Neurology, October 2005, Wolters Kluwer Health

    Professor Irene Litvan, Professor Dr. Durval C. COSTA

  213. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy

    Article • Human Molecular Genetics, September 2005, Oxford University Press (OUP)

    Professor Irene Litvan

  214. Cognitive and behavioral aspects of PSP since Steele, Richardson and Olszewski’s description of PSP 40 years ago and Albert’s delineation of the subcortical dementia 30 years ago

    Article • Neurocase, August 2005, Taylor & Francis

    Professor Irene Litvan

  215. “Applause sign” helps to discriminate PSP from FTD and PD

    Article • Neurology, June 2005, Wolters Kluwer Health

    Professor Irene Litvan

  216. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome

    Article • Movement Disorders, April 2005, Wiley

    Professor Irene Litvan

  217. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response

    Article • Brain, January 2005, Oxford University Press (OUP)

    MD, PhD Gerardo Lopez Flores, Professor Irene Litvan

  218. Atypical Parkinsonian Disorders

    Article • January 2005, Springer Science + Business Media

    Professor Irene Litvan

  219. What is an Atypical Parkinsonian Disorder?

    Article • January 2005, Springer Science + Business Media

    Professor Irene Litvan

  220. Progressive Supranuclear Palsy

    Article • January 2005, Springer Science + Business Media

    Professor Irene Litvan

  221. Progressive Supranuclear Palsy and Corticobasal Degeneration

    Article • January 2005, Elsevier

    Professor Irene Litvan

  222. Update on progressive supranuclear palsy

    Article • Current Neurology and Neuroscience Reports, July 2004, Springer Science + Business Media

    Professor Irene Litvan

  223. ATYPICAL PARKINSONIAN DISORDERS

    Article • Continuum, June 2004, Wolters Kluwer Health

    Professor Irene Litvan

  224. Diagnostic issues in non-AD dementias

    Article • Clinical Neuroscience Research, March 2004, Elsevier

    Professor Irene Litvan

  225. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration

    Article • NeuroImage, February 2004, Elsevier

    Professor Irene Litvan

  226. Verifying Clinical Criteria for Parkinsonian Disorders with CART Decision Trees

    Article • January 2004, Springer Science + Business Media

    Professor Irene Litvan, Professor Peter Kokol

  227. Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?

    Article • Movement Disorders, October 2003, Wiley

    Professor Irene Litvan

  228. Update on epidemiological aspects of progressive supranuclear palsy

    Article • Movement Disorders, September 2003, Wiley

    Professor Irene Litvan

  229. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease

    Article • Journal of Neurology Neurosurgery & Psychiatry, September 2003, BMJ

    Professor Irene Litvan

  230. SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

    Article • Movement Disorders, April 2003, Wiley

    Professor Irene Litvan

  231. Progression of gait, speech and swallowing deficits in progressive supranuclear palsy

    Article • Neurology, March 2003, Wolters Kluwer Health

    Professor Irene Litvan

  232. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia

    Article • Annals of Neurology, January 2003, Wiley

    Professor Irene Litvan

  233. Yes/no reversals as neurobehavioral sequela: a disorder of language, praxis, or inhibitory control?

    Article • European Journal of Neurology, January 2003, Wiley

    Professor Irene Litvan

  234. Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration

    Article • Journal of Neuropathology & Experimental Neurology, November 2002, Oxford University Press (OUP)

    Professor Irene Litvan

  235. Freezing of gait in postmortem‐confirmed atypical parkinsonism

    Article • Movement Disorders, April 2002, Wiley

    Professor Irene Litvan, Nadia Stefanova

  236. Mitochondrial Dysfunction in Cybrid Lines Expressing Mitochondrial Genes from Patients with Progressive Supranuclear Palsy

    Article • Journal of Neurochemistry, January 2002, Wiley

    Professor Irene Litvan

  237. Corticobasal Degeneration and Related Disorders

    Article • European Journal of Neurology, November 2001, Wiley

    Professor Irene Litvan

  238. Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease

    Article • European Journal of Neurology, November 2001, Wiley

    Professor Irene Litvan

  239. Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders

    Article • Movement Disorders, November 2001, Wiley

    Professor Irene Litvan

  240. Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy

    Article • Neurology, August 2001, Wolters Kluwer Health

    Professor Irene Litvan

  241. Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype

    Article • BMC Neurology, July 2001, Springer Science + Business Media

    Professor Irene Litvan

  242. Tau genotype: No effect on onset, symptom severity, or survival in progressive supranuclear palsy

    Article • Neurology, July 2001, Wolters Kluwer Health

    Professor Irene Litvan

  243. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype

    Article • Neurology, June 2001, Wolters Kluwer Health

    Professor Irene Litvan

  244. Therapy and management of frontal lobe dementia patients

    Article • Neurology, June 2001, Wolters Kluwer Health

    Professor Irene Litvan

  245. Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy

    Article • Neurology, April 2001, Wolters Kluwer Health

    Professor Irene Litvan

  246. An open letter to the Committee on The Nobel Prize in Medicine

    Article • Parkinsonism & Related Disorders, April 2001, Elsevier

    Professor Irene Litvan

  247. Impairment of eyeblink classical conditioning in progressive supranuclear palsy

    Article • Movement Disorders, March 2001, Wiley

    Professor Irene Litvan

  248. Progression of Dysarthria and Dysphagia in Postmortem-Confirmed Parkinsonian Disorders

    Article • Archives of Neurology, February 2001, American Medical Association (AMA)

    Professor Irene Litvan

  249. Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson's Disease

    Article • Journal of Neuropsychiatry, February 2001, American Psychiatric Association

    Professor Irene Litvan

  250. Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson's Disease

    Article • Journal of Neuropsychiatry, February 2001, American Psychiatric Association

    Professor Irene Litvan

  251. Diagnosis and Management of Progressive Supranuclear Palsy

    Article • Seminars in Neurology, January 2001, Thieme Publishing Group

    Professor Irene Litvan

  252. The FAB

    Article • Neurology, December 2000, Wolters Kluwer Health

    Professor Irene Litvan

  253. Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study

    Article • Neurology, September 2000, Wolters Kluwer Health

    Professor Irene Litvan

  254. Research goals in progressive supranuclear palsy

    Article • Movement Disorders, May 2000, Wiley

    Professor Irene Litvan

  255. Scientific position paper of the Movement Disorder Society evaluation of surgery for Parkinson's disease

    Article • Movement Disorders, May 2000, Wiley

    Professor Irene Litvan

  256. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy

    Article • Neurology, March 2000, Wolters Kluwer Health

    Professor Irene Litvan

  257. Language disturbances in corticobasal degeneration

    Article • Neurology, February 2000, Wolters Kluwer Health

    Professor Irene Litvan

  258. Pupillary diameter assessment: Need for a graded scale

    Article • Neurology, January 2000, Wolters Kluwer Health

    Professor Irene Litvan

  259. Frontal Assessment Battery

    Article • January 2000, American Psychological Association (APA)

    Professor Irene Litvan

  260. Importance of deficits in executive functions

    Article • The Lancet, December 1999, Elsevier

    Professor Irene Litvan

  261. Evaluation of surgery for Parkinson’s disease

    Article • Neurology, December 1999, Wolters Kluwer Health

    Professor Irene Litvan

  262. Progression of falls in postmortem-confirmed Parkinsonian disorders

    Article • Movement Disorders, November 1999, Wiley

    Professor Irene Litvan

  263. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study

    Article • Journal of Neurology Neurosurgery & Psychiatry, November 1999, BMJ

    Professor Irene Litvan

  264. Atypical parkinsonism in the French West Indies

    Article • The Lancet, October 1999, Elsevier

    Professor Irene Litvan

  265. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias

    Article • Neurology, October 1999, Wolters Kluwer Health

    Professor Irene Litvan

  266. Recent advances in atypical parkinsonian disorders

    Article • Current Opinion in Neurology, August 1999, Wolters Kluwer Health

    Professor Irene Litvan

  267. Effects of Physostigmine on Swallowing and Oral Motor Functions in Patients with Progressive Supranuclear Palsy: A Pilot Study

    Article • Dysphagia, May 1999, Springer Science + Business Media

    Professor Irene Litvan

  268. Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy

    Article • Human Molecular Genetics, April 1999, Oxford University Press (OUP)

    Professor Irene Litvan

  269. Clinicopathologic Case Report

    Article • Journal of Neuropsychiatry, February 1999, American Psychiatric Association

    Professor Irene Litvan

  270. Consensus statement on the diagnosis of multiple system atrophy

    Article • Journal of the Neurological Sciences, February 1999, Elsevier

    Professor Irene Litvan

  271. Ideomotor apraxia in progressive supranuclear palsy: A case study

    Article • Movement Disorders, January 1999, Wiley

    Professor Irene Litvan

  272. Ideomotor apraxia in progressive supranuclear palsy: A case study

    Article • Movement Disorders, January 1999, Wiley

    Professor Irene Litvan

  273. A lack of the R406W tau mutation in progressive supranuclear palsy and corticobasal degeneration

    Article • Neurology, January 1999, Wolters Kluwer Health

    Professor Irene Litvan

  274. Consensus statement on the diagnosis of multiple system atrophy

    Article • Clinical Autonomic Research, December 1998, Springer Science + Business Media

    Professor Irene Litvan

  275. Parkinsonian Features

    Article • JAMA, November 1998, American Medical Association (AMA)

    Professor Irene Litvan

  276. Caregiving in progressive supranuclear palsy

    Article • Neurology, November 1998, Wolters Kluwer Health

    Professor Irene Litvan

  277. Neuropsychiatric features of corticobasal degeneration

    Article • Journal of Neurology Neurosurgery & Psychiatry, November 1998, BMJ

    Professor Irene Litvan

  278. Neuropsychiatric Assessment of Patients With Hyperkinetic and Hypokinetic Movement Disorders

    Article • Archives of Neurology, October 1998, American Medical Association (AMA)

    Professor Irene Litvan

  279. Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study

    Article • European Journal of Neurology, September 1998, Wiley

    Professor Irene Litvan

  280. Reliability of the NINDS Myotatic Reflex Scale

    Article • Neurology, September 1998, Wolters Kluwer Health

    Professor Irene Litvan

  281. Pharmacological Therapy in Progressive Supranuclear Palsy

    Article • Archives of Neurology, August 1998, American Medical Association (AMA)

    Professor Irene Litvan

  282. Is EEG useful in the differential diagnosis of parkinsonism?

    Article • Parkinsonism & Related Disorders, August 1998, Elsevier

    Professor Irene Litvan

  283. Apathy Is Not Depression

    Article • Journal of Neuropsychiatry, August 1998, American Psychiatric Association

    Professor Irene Litvan

  284. Dysfunction of Ib (Autogenic) spinal inhibition in patients with progressive supranuclear palsy

    Article • Movement Disorders, July 1998, Wiley

    Professor Irene Litvan

  285. Clinical and Genetic Aspects of Progressive Supranuclear Palsy

    Article • Journal of Geriatric Psychiatry and Neurology, July 1998, SAGE Publications

    Professor Irene Litvan

  286. Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies

    Article • Archives of Neurology, July 1998, American Medical Association (AMA)

    Professor Irene Litvan

  287. Progressive supranuclear palsy

    Article • Neurology, June 1998, Wolters Kluwer Health

    Professor Irene Litvan

  288. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy

    Article • Journal of Neural Transmission, May 1998, Springer Science + Business Media

    Professor Irene Litvan

  289. Apolipoprotein Eepsilon4 (Epsilon) Allele Does Not Affect the Onset or Symptom Severity in Progressive Supranuclear Palsy

    Article • Archives of Neurology, May 1998, American Medical Association (AMA)

    Professor Irene Litvan

  290. What are the Obstacles for an Accurate Clinical Diagnosis of Pick's disease?

    Article • Neurology, April 1998, Wolters Kluwer Health

    Professor Irene Litvan

  291. Methodological and Research Issues in the Evaluation of Biological Diagnostic Markers for Alzheimer’s Disease

    Article • Neurobiology of Aging, March 1998, Elsevier

    Professor Irene Litvan

  292. Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI). 22The ...

    Article • Neurobiology of Aging, March 1998, Elsevier

    Professor Irene Litvan

  293. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

    Article • Journal of Neurology Neurosurgery & Psychiatry, February 1998, BMJ

    Professor Irene Litvan

  294. PROGRESSIVE SUPRANUCLEAR PALSY

    Article • The Neurologist, January 1998, Wolters Kluwer Health

    Professor Irene Litvan

  295. Limb shaking in multiple system atrophy

    Article • European Journal of Neurology, January 1998, Wiley

    Professor Irene Litvan

  296. Progressive supranuclear gaze palsy is in linkage disequilibrium with theτ and not the α-synuclein gene

    Article • Neurology, January 1998, Wolters Kluwer Health

    Professor Irene Litvan

  297. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration

    Article • Brain, September 1997, Oxford University Press (OUP)

    Professor Irene Litvan

  298. What Is the Accuracy of the Clinical Diagnosis of Multiple System Atrophy?

    Article • Archives of Neurology, August 1997, American Medical Association (AMA)

    Professor Irene Litvan

  299. The clinical and pathologic hallmarks of progressive supranuclear palsy

    Article • Current Opinion in Neurology, August 1997, Wolters Kluwer Health

    Professor Irene Litvan

  300. Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism

    Article • Journal of Neural Transmission, August 1997, Springer Science + Business Media

    Professor Irene Litvan

  301. What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study

    Article • Neurology, July 1997, Wolters Kluwer Health

    Professor Irene Litvan

  302. Characterizing swallowing abnormalities in progressive supranuclear palsy

    Article • Neurology, June 1997, Wolters Kluwer Health

    Professor Irene Litvan

  303. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study

    Article • Brain, January 1997, Oxford University Press (OUP)

    Professor Irene Litvan

  304. Accuracy of the Clinical Diagnosis of Corticobasal Degeneration: A Clinicopathologic Study

    Article • Neurology, January 1997, Wolters Kluwer Health

    Professor Irene Litvan

  305. REPLY FROM THE AUTHORS

    Article • Journal of Neuropathology & Experimental Neurology, December 1996, Oxford University Press (OUP)

    Professor Irene Litvan

  306. A Reappraisal of Reliability and Validity Studies in Stroke

    Article • Stroke, December 1996, Wolters Kluwer Health

    Professor Irene Litvan

  307. Neuropsychiatric aspects of progressive supranuclear palsy

    Article • Neurology, November 1996, Wolters Kluwer Health

    Professor Irene Litvan

  308. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?

    Article • Neurology, November 1996, Wolters Kluwer Health

    Professor Irene Litvan

  309. Reliability of the NINDS Myotatic Reflex Scale

    Article • Neurology, October 1996, Wolters Kluwer Health

    Professor Irene Litvan

  310. Preserved cognitive processes in cerebellar degeneration

    Article • Behavioural Brain Research, September 1996, Elsevier

    Professor Irene Litvan

  311. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop

    Article • Neurology, July 1996, Wolters Kluwer Health

    Professor Irene Litvan

  312. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

    Article • Journal of Neurology Neurosurgery & Psychiatry, June 1996, BMJ

    Professor Irene Litvan

  313. Visualizing Cortical Activation during Mental Calculation with Functional MRI

    Article • NeuroImage, April 1996, Elsevier

    Professor Irene Litvan, Denis Le Bihan

  314. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

    Article • Neurology, April 1996, Wolters Kluwer Health

    Professor Irene Litvan

  315. Progressive supranuclear palsy: a clinicopathological study of 21 cases

    Article • Acta Neuropathologica, March 1996, Springer Science + Business Media

    Professor Irene Litvan

  316. 641 Accuracy of the clinical diagnosis of pick's disease

    Article • Neurobiology of Aging, January 1996, Elsevier

    Professor Irene Litvan

  317. Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders

    Article • Journal of Neuropathology & Experimental Neurology, January 1996, Oxford University Press (OUP)

    Professor Irene Litvan

  318. What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features?

    Article • Brain, January 1996, Oxford University Press (OUP)

    Professor Irene Litvan

  319. Neuropsychological Features of Progressive Supranuclear Palsy

    Article • Brain and Cognition, August 1995, Elsevier

    Professor Irene Litvan

  320. What can preservation of autobiographic memory after muscarinic blockade tell us about the scopolamine model of dementia?

    Article • Neurology, February 1995, Wolters Kluwer Health

    Professor Irene Litvan

  321. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)

    Article • Neurology, November 1994, Wolters Kluwer Health

    Professor Irene Litvan

  322. Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy

    Article • Annals of Neurology, July 1994, Wiley

    Professor Irene Litvan

  323. Cognitive disturbances in progressive supranuclear palsy

    Article • January 1994, Springer Science + Business Media

    Professor Irene Litvan

  324. Cholinergic approaches to the treatment of progressive supranuclear palsy

    Article • January 1994, Springer Science + Business Media

    Professor Irene Litvan

  325. Cerebellar cognition

    Article • Neurology, October 1993, Wolters Kluwer Health

    Professor Irene Litvan

  326. Cognitive planning deficit in patients with cerebellar atrophy

    Article • Neurology, August 1992, Wolters Kluwer Health

    Professor Irene Litvan

  327. CSF galanin and neuropeptide Y immunoreactivity in progressive supranuclear palsy

    Article • Acta Neurologica Scandinavica, August 1992, Hindawi Publishing Corporation

    Professor Irene Litvan

  328. Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine.

    Article • Journal of Neurology Neurosurgery & Psychiatry, September 1991, BMJ

    Professor Irene Litvan

  329. Progressive supranuclear palsy

    Article • Neurology, August 1991, Wolters Kluwer Health

    Professor Irene Litvan

  330. Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.

    Article • Journal of Neurology Neurosurgery & Psychiatry, January 1991, BMJ

    Professor Irene Litvan

  331. Effects of Physostigmine on Spatial Attention in Patients With Progressive Supranuclear Palsy

    Article • Archives of Neurology, December 1990, American Medical Association (AMA)

    Professor Irene Litvan

  332. Selective Deficits in Alzheimer and Parkinsonian Dementia: Visuospatial Function

    Article • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, August 1990, Cambridge University Press

    Professor Irene Litvan

  333. Selective deficits in cognition and memory in high-functioning parkinsonian patients.

    Article • Journal of Neurology Neurosurgery & Psychiatry, July 1990, BMJ

    Professor Irene Litvan

  334. Frontal Lobe Function in Progressive Supranuclear Palsy

    Article • Archives of Neurology, May 1990, American Medical Association (AMA)

    Professor Irene Litvan

  335. Implicit Learning in Patients with Alzheimer's Disease

    Article • Pharmacopsychiatry, March 1990, Thieme Publishing Group

    Professor Irene Litvan

  336. Physostigmine treatment of progressive supranuclear palsy

    Article • Annals of Neurology, September 1989, Wiley

    Professor Irene Litvan

  337. Memory Impairment in Patients With Progressive Supranuclear Palsy

    Article • Archives of Neurology, July 1989, American Medical Association (AMA)

    Professor Irene Litvan

  338. Multiple Memory Deficits in Patients With Multiple Sclerosis

    Article • Archives of Neurology, June 1988, American Medical Association (AMA)

    Professor Irene Litvan

  339. Slowed Information Processing in Multiple Sclerosis

    Article • Archives of Neurology, March 1988, American Medical Association (AMA)

    Professor Irene Litvan

  340. Unilateral left cerebral deterioration documented by CT, MRI, and neuropsychological studies: A possible case of pick's disease

    Article • Developmental Neuropsychology, January 1988, Taylor & Francis

    Professor Irene Litvan

  341. Behcet's syndrome masquerading as tumor

    Article • Neuroradiology, January 1987, Springer Science + Business Media

    Professor Irene Litvan

  342. Does reversed laterality really exist in dextrals? A case study

    Article • Neuropsychologia, January 1986, Elsevier

    Professor Irene Litvan

  343. Agitation and Apathy in Hyper- and Hypokinetic Movement Disorders

    Article • Springer Science + Business Media

    Professor Irene Litvan

  344. Measuring quality of life in progressive supranuclear palsy

    Article • Cambridge University Press

    Professor Irene Litvan

  345. Management of cognitive impairment in Parkinson's disease

    Article • Cambridge University Press

    Professor Irene Litvan

  346. Faculty of 1000 evaluation for Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.

    Article • Faculty of 1000, Ltd.

    Professor Irene Litvan

  347. Article • PLOS

    Professor Irene Litvan

  348. Article • PLOS

    Professor Irene Litvan

  349. Case Studies

    Article • Wiley

    Professor Irene Litvan